Wellgistics Health, Inc.(WGRX)Earnings, Financials & Key Ratios
WGRX•NASDAQ
$0.09
$8M mkt cap·Price updated May 6, 2026
AboutWellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.Show more
- Revenue$18M
- EBITDA-$5M-74.6%
- Net Income-$7M-136.8%
- EPS (Diluted)-0.13-116.7%
- Gross Margin9.75%
- EBITDA Margin-27.75%
- Operating Margin-33.9%
- Net Margin-37.82%
- ROE-357.65%
- ROIC-32.21%
- Debt/Equity3.73
- Interest Coverage-7.39+96.1%
WGRX Key Insights
Wellgistics Health, Inc. (WGRX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.7x book value
✗Weaknesses
- ✗High debt to equity ratio of 3.7x
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 2 (bottom 2%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 16.2% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
WGRX Price & Volume
Wellgistics Health, Inc. (WGRX) stock price & volume — 10-year historical chart
Loading chart...
WGRX Growth Metrics
Wellgistics Health, Inc. (WGRX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-91.8%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-284.38%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-279.78%
Return on Capital
10 Years-73.44%
5 Years-73.44%
3 Years-73.44%
Last Year-73.44%
WGRX Peer Comparison
Wellgistics Health, Inc. (WGRX) competitors in Drug Wholesalers and Distributors — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HSIC | 8.31B | 72.44 | 22.15 | 4.03% | 3.02% | 8.24% | 0.77 | |
 OMI | 171.11M | 2.24 | -0.16 | -74.19% | -39.85% | -21.12% | ||
 HCSG | 1.58B | 22.07 | 27.25 | 7.08% | 3.21% | 11.83% | 0.05 | |
 MCK | 91.09B | 743.67 | 28.91 | 16.22% | 1.09% | |||
 CAH | 45.06B | 191.49 | 29.69 | -1.87% | 0.62% | |||
 PAHC | 2.38B | 58.64 | 49.28 | 27.37% | 6.29% | 30.81% | 2.67 | |
 RDNT | 4.54B | 58.64 | -234.56 | 11.51% | 2.29% | 3.75% | 1.37 | |
 CVS | 111.32B | 86.86 | 62.49 | 7.85% | 0.72% | 3.86% | 1.24 |
Compare WGRX vs Peers
Wellgistics Health, Inc. (WGRX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
WGRX Income Statement
Wellgistics Health, Inc. (WGRX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'23 | Dec'24 | TTM |
|---|---|---|---|
| Sales/Revenue | 0 | 18.13M | 5.62M |
| Revenue Growth % | - | - | -91.8% |
| Cost of Goods Sold | 0 | 16.36M | 5.39M |
| COGS % of Revenue | - | 90.25% | - |
| Gross Profit | 0▲ 0% | 1.77M▲ 0% | 231.81K▲ 0% |
| Gross Margin % | - | 9.75% | 4.13% |
| Gross Profit Growth % | - | - | - |
| Operating Expenses | 2.88M | 7.91M | 67.3M |
| OpEx % of Revenue | - | 43.65% | - |
| Selling, General & Admin | 2.88M | 6.8M | 68.08M |
| SG&A % of Revenue | - | 37.5% | - |
| Research & Development | 375 | 0 | 0 |
| R&D % of Revenue | - | - | - |
| Other Operating Expenses | -375 | 1.11M | 605.67K |
| Operating Income | -2.88M▲ 0% | -6.15M▼ 113.3% | -67.87M▲ 0% |
| Operating Margin % | - | -33.9% | -1207.81% |
| Operating Income Growth % | - | -113.33% | - |
| EBITDA | -2.88M | -5.03M | -64.81M |
| EBITDA Margin % | - | -27.75% | -1153.42% |
| EBITDA Growth % | - | -74.63% | -645.66% |
| D&A (Non-Cash Add-back) | 0 | 1.11M | 3.06M |
| EBIT | -2.88M | -6.02M | -36.81M |
| Net Interest Income | -15.08K | -831.47K | -3.36M |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | 15.08K | 831.47K | 3.36M |
| Other Income/Expense | -15.08K | -711.09K | -5.2M |
| Pretax Income | -2.9M▲ 0% | -6.86M▼ 136.8% | -73.07M▲ 0% |
| Pretax Margin % | - | -37.82% | -1300.34% |
| Income Tax | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% |
| Net Income | -2.9M▲ 0% | -6.86M▼ 136.8% | -73.07M▲ 0% |
| Net Margin % | - | -37.82% | -1300.34% |
| Net Income Growth % | - | -136.77% | -284.38% |
| Net Income (Continuing) | -2.9M | -6.86M | -38.75M |
| Discontinued Operations | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| EPS (Diluted) | -0.06▲ 0% | -0.13▼ 116.7% | -0.98▲ 0% |
| EPS Growth % | - | -116.67% | -279.78% |
| EPS (Basic) | -0.06 | -0.13 | - |
| Diluted Shares Outstanding | 44.72M | 51.94M | 74.38M |
| Basic Shares Outstanding | 44.72M | 51.94M | 74.38M |
| Dividend Payout Ratio | - | - | - |
WGRX Balance Sheet
Wellgistics Health, Inc. (WGRX) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'23 | Dec'24 | TTM |
|---|---|---|---|
| Total Current Assets | 338.36K | 15.17M | 12.82M |
| Cash & Short-Term Investments | 1.36K | 1.03M | 4.23M |
| Cash Only | 1.36K | 1.03M | 4.23M |
| Short-Term Investments | 0 | 0 | 0 |
| Accounts Receivable | 337K | 3.75M | 1.1M |
| Days Sales Outstanding | - | 75.42 | 207.95 |
| Inventory | 0 | 9.52M | 7.49M |
| Days Inventory Outstanding | - | 212.35 | 605.96 |
| Other Current Assets | 0 | 875.39K | 0 |
| Total Non-Current Assets | 0 | 42.16M | 39.96M |
| Property, Plant & Equipment | 0 | 1.92M | 1.29M |
| Fixed Asset Turnover | - | 9.46x | 3.43x |
| Goodwill | 0 | 16.22M | 16.22M |
| Intangible Assets | 0 | 22.36M | 18.46M |
| Long-Term Investments | 0 | 17.67K | 314.88K |
| Other Non-Current Assets | 0 | 1.65M | 8.67M |
| Total Assets | 338.36K▲ 0% | 57.33M▲ 16844.1% | 52.78M▲ 0% |
| Asset Turnover | - | 0.32x | 0.10x |
| Asset Growth % | - | 16844.08% | 16927.91% |
| Total Current Liabilities | 2.89M | 38.05M | 32.74M |
| Accounts Payable | 1.04M | 6.33M | 10.41M |
| Days Payables Outstanding | - | 141.31 | 583.22 |
| Short-Term Debt | 350K | 12.04M | 12.94M |
| Deferred Revenue (Current) | 0 | 245.76K | 793.3K |
| Other Current Liabilities | 950K | 3.11M | 4.87M |
| Current Ratio | 0.12x | 0.40x | 0.40x |
| Quick Ratio | 0.12x | 0.15x | 0.15x |
| Cash Conversion Cycle | - | 146.46 | 230.69 |
| Total Non-Current Liabilities | 350K | 12.55M | 13.26M |
| Long-Term Debt | 350K | 11.46M | 13.26M |
| Capital Lease Obligations | 0 | 1.1M | 2.87M |
| Deferred Tax Liabilities | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 |
| Total Liabilities | 3.24M | 50.6M | 46M |
| Total Debt | 700K | 25.11M | 26.2M |
| Net Debt | 698.64K | 24.08M | 21.97M |
| Debt / Equity | - | 3.73x | 3.73x |
| Debt / EBITDA | - | - | -0.40x |
| Net Debt / EBITDA | - | - | -0.34x |
| Interest Coverage | -191.01x | -7.39x | -10.95x |
| Total Equity | -2.9M▲ 0% | 6.73M▲ 332.2% | 6.78M▲ 0% |
| Equity Growth % | - | 332.19% | 4816473.24% |
| Book Value per Share | -0.06 | 0.13 | 0.09 |
| Total Shareholders' Equity | -2.9M | 6.73M | 6.78M |
| Common Stock | 4.47K | 5.11K | 8.95K |
| Retained Earnings | -2.9M | -9.76M | -83.18M |
| Treasury Stock | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
WGRX Cash Flow Statement
Wellgistics Health, Inc. (WGRX) cash flow — operating, investing & free cash flow history
| Line item | Dec'23 | Dec'24 | TTM |
|---|---|---|---|
| Cash from Operations | -349.14K | -1.22M | -1.22M |
| Operating CF Margin % | - | -6.76% | - |
| Operating CF Growth % | - | -250.86% | -7848.01% |
| Net Income | -2.9M | -6.86M | -73.07M |
| Depreciation & Amortization | 0 | 1.11M | 3.06M |
| Stock-Based Compensation | 0 | 1.08M | 54.44M |
| Deferred Taxes | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 93.38K | 3.21M |
| Working Capital Changes | 2.55M | 3.34M | 9.83M |
| Change in Receivables | 0 | -40.08K | 1.36M |
| Change in Inventory | 0 | -72.36K | 2.32M |
| Change in Payables | 1.03M | -882.32K | 3.06M |
| Cash from Investing | 0 | 469.07K | 212.26K |
| Capital Expenditures | 0 | -377.29K | -112.44K |
| CapEx % of Revenue | - | 2.08% | - |
| Acquisitions | 0 | 931.37K | 1M |
| Investments | - | - | - |
| Other Investing | 0 | -85.01K | -675.3K |
| Cash from Financing | 350.5K | 1.78M | 10.44M |
| Debt Issued (Net) | 350K | 620.7K | -843.38K |
| Equity Issued (Net) | 500 | 10K | 2.41M |
| Dividends Paid | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 |
| Other Financing | 0 | 1.15M | 340.16K |
| Net Change in Cash | 1.36K▲ 0% | 1.03M▲ 75191.2% | 3.44M▲ 0% |
| Free Cash Flow | -349.14K▲ 0% | -1.6M▼ 358.9% | -7.33M▲ 0% |
| FCF Margin % | - | -8.84% | -130.52% |
| FCF Growth % | - | -358.93% | -1070.69% |
| FCF per Share | -0.01 | -0.03 | -0.03 |
| FCF Conversion (FCF/Net Income) | 0.12x | 0.18x | 0.10x |
| Interest Paid | 0 | 0 | 1.48M |
| Taxes Paid | 0 | 0 | 0 |
WGRX Key Ratios
Wellgistics Health, Inc. (WGRX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2024 | TTM |
|---|---|---|
| Return on Equity (ROE) | -357.65% | -1077.99% |
| Return on Invested Capital (ROIC) | -32.21% | -32.21% |
| Gross Margin | 9.75% | 4.13% |
| Net Margin | -37.82% | -1300.34% |
| Debt / Equity | 3.73x | 3.73x |
| Interest Coverage | -7.39x | -10.95x |
| FCF Conversion | 0.18x | 0.10x |
| Revenue Growth | - | -91.8% |
WGRX Frequently Asked Questions
Wellgistics Health, Inc. (WGRX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Wellgistics Health, Inc. (WGRX) reported $5.6M in revenue for fiscal year 2024.
Wellgistics Health, Inc. (WGRX) grew revenue by 0.0% over the past year. Growth has been modest.
Wellgistics Health, Inc. (WGRX) reported a net loss of $73.1M for fiscal year 2024.
Dividend & Returns
Wellgistics Health, Inc. (WGRX) has a return on equity (ROE) of -357.7%. Negative ROE indicates the company is unprofitable.
Wellgistics Health, Inc. (WGRX) had negative free cash flow of $7.3M in fiscal year 2024, likely due to heavy capital investments.
Explore More WGRX
Wellgistics Health, Inc. (WGRX) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates